Jaguar Health (NASDAQ:JAGX) Stock Price Passes Above Fifty Day Moving Average – Here’s What Happened

Jaguar Health, Inc. (NASDAQ:JAGX) shares crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.02 and traded as high as $1.20. Jaguar Health shares last traded at $1.09, with a volume of 425,377 shares traded.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded Jaguar Health from a “sell” rating to a “hold” rating in a report on Friday, September 13th.

Jaguar Health Price Performance

The company has a quick ratio of 1.36, a current ratio of 1.84 and a debt-to-equity ratio of 1.65. The stock’s fifty day simple moving average is $1.02 and its 200 day simple moving average is $1.52.

Institutional Investors Weigh In On Jaguar Health

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC acquired a new stake in Jaguar Health, Inc. (NASDAQ:JAGX) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned approximately 0.22% of Jaguar Health at the end of the most recent quarter. 12.04% of the stock is currently owned by institutional investors and hedge funds.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.